Universal Ibogaine Inc. (TSXV:IBO)
Canada
· Delayed Price · Currency is CAD 0.0050
-0.0050 (-50.00%)
At close: Feb 2, 2026
Universal Ibogaine Company Description
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada.
The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment.
Universal Ibogaine Inc. is headquartered in Calgary, Canada.
Universal Ibogaine Inc.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Nicholas Karos |
Contact Details
Address: 815 8th Avenue SW Calgary, AB T2P 3P2 Canada | |
| Phone | 855-426-4246 |
| Website | universalibogaine.com |
Stock Details
| Ticker Symbol | IBO |
| Exchange | TSX Venture Exchange |
| Fiscal Year | August - July |
| Reporting Currency | CAD |
| ISIN Number | CA91360F1099 |
| SIC Code | 8063 |
Key Executives
| Name | Position |
|---|---|
| Nicholas Peter Karos | Chief Executive Officer, Director of Capital Markets and Director |
| Shayne Nyquvest | Co-Founder |
| Cathy Fernandes | Vice President of Marketing and VP of Communications |